Con Biovia, Dassault Systèmes brings modeling and simulation to scientific innovation

Biovia is the new brand of Dassault Systems that combines Accelrys, BioPLM and 3Dexperience to offer biological modeling and simulation solutions, chemistry and materials. Provides product lifecycle experiences, globally and collaboratively, that allow the transformation of scientific innovations.

 

The new brand of Dassault Systèmes It is called Biovia and is the result of the combination of the company's activities in BioIntelligence., its 3Dexperience collaborative technologies and life sciences and physics applications from the recent acquisition of Accelrys.

Biovia solutions focus on biological modeling and simulation, chemistry and materials; open collaborative research, company laboratories, quality management and intelligence in manufacturing processes.

Biovia provides a wide offering for modeling, simulation and production in biological fields, chemical and materials. Among the more than 2.000 customers of the new brand of Dassault Systems appear companies in Fortune 500 like Sanofi, Pfizer, GSK, AstraZeneca, DuPont, Shell, BASF, P&G, Unilever and L’Oréal.

Biovia will provide scientific experiences, biological, chemicals and materials for the entire enterprise with the next generation of applications, services, access and delivery of content offered by the Dassault Systèmes 3Dexperience enterprise platform. From materials design to molecular simulation and chemical manufacturing, The objective is for Biovia to act as a disruptive catalyst to provide scientific universes capable of harmonizing products, nature and life.

“Dassault Systèmes' previous research programs, in the fields of life sciences and BioIntelligence, were the forerunners of the brand and current capabilities. The integration of Accelrys applications with our 3Dexperience platform will give rise to a new collaborative environment for the development of advanced experiences in the biological field, chemical and materials. With the power of Biovia, we will model the entire biosphere”, explains Bernard Charles, President and CEO of Dassault Systèmes.

The integration of the 3Dexperience platform with the Accelrys application suite opens a wide range of opportunities to support and develop systemic collaboration, project management, the reuse of data and content, traceability and other processes, applications and integrations that are absolutely critical in scientific industries, including pharmaceutical companies that must face major challenges related to innovation and the development of new drugs.

“We want to provide industry and science with the necessary applications to model the biosphere. Biovia offers a systemic collaborative approach for any company that promotes innovation in the pharmaceutical industries, consumer goods and other process industries”, highlights Max Carnecchia, CEO of Biovia of Dassault Systèmes. “The sophisticated business modeling system, simulation, laboratory and quality management makes innovation possible in practically any industry.”

Aside from key innovators and leaders in the pharmaceutical and biotechnology industries, major manufacturing companies such as Boeing, Toyota or Samsung are using Biovia solutions to explore and bring new materials to the market, like smart covers, light and resistant compounds and innovations in ecological materials.

These companies are reaching the point of using material as a variable and not as a limitation. For this, The ability to manage product information at a molecular level and in a scalable manner is essential throughout the value chain. Besides, the current aggressive industrialization of research processes, Development and manufacturing is driving the adoption of an integrated business platform capable of managing diverse types of information in collaborative and regulatory compliant environments.